|
Volumn 22, Issue 2, 2002, Pages 224-226
|
Effects of oral procyclidine administration on cognitive functions in healthy subjects: Implications for schizophrenia [2]
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
PLACEBO;
PROCYCLIDINE;
ADULT;
CLINICAL TRIAL;
COGNITION;
COGNITIVE DEFECT;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIAGNOSTIC TEST;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG BLOOD LEVEL;
HUMAN;
HUMAN EXPERIMENT;
LETTER;
MALE;
MEMORY;
MULTIVARIATE ANALYSIS OF VARIANCE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SCHIZOPHRENIA;
TASK PERFORMANCE;
ADMINISTRATION, ORAL;
ADULT;
CHOLINERGIC ANTAGONISTS;
COGNITION DISORDERS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
NEUROPSYCHOLOGICAL TESTS;
PROCYCLIDINE;
SCHIZOPHRENIA;
|
EID: 0036219231
PISSN: 02710749
EISSN: None
Source Type: Journal
DOI: 10.1097/00004714-200204000-00020 Document Type: Letter |
Times cited : (18)
|
References (20)
|